| scholarly article | Q13442814 |
| P50 | author | George G Zhanel | Q87082624 |
| James A. Karlowsky | Q88392142 | ||
| P2093 | author name string | George G Zhanel | |
| Andrew Walkty | |||
| Heather J Adam | |||
| Melanie R Baxter | |||
| P2860 | cites work | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Q29617469 |
| Synthesis and spectrum of the neoglycoside ACHN-490 | Q34134992 | ||
| Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin | Q34269044 | ||
| Plazomicin: an investigational therapy for the treatment of urinary tract infections. | Q34673393 | ||
| Aminoglycoside Resistance: The Emergence of Acquired 16S Ribosomal RNA Methyltransferases | Q36930694 | ||
| ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates | Q37392705 | ||
| Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes | Q37612977 | ||
| Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America | Q42111977 | ||
| Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals | Q43762226 | ||
| Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers | Q46244641 | ||
| Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis: A Multicenter, Randomized, Double-Blind, Phase 2 Study | Q49598865 | ||
| Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates | Q49934971 | ||
| In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE). | Q52841787 | ||
| High prevalence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacteriaceae in the UK & Ireland. | Q53700318 | ||
| Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes. | Q54205904 | ||
| Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City | Q82736865 | ||
| In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes | Q88984613 | ||
| Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms | Q91467924 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plazomicin | Q15426988 |
| P577 | publication date | 2018-12-21 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Bacterial Pathogens Isolated from Patients in Canadian Hospitals from 2013 to 2017 as Part of the CANWARD Surveillance Study | |
| P478 | volume | 63 |
| Q89864930 | Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals (2016-2017): Effect of Different Breakpoint Criteria on in the Susceptibility Rates among Aminoglycosides |
| Q99580010 | Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance |
Search more.